Target intelligence / Profile preview

Novel transcript, antisense to LASP1

Molecular classification
Antisense non-coding RNA, Long non-coding RNA (lncRNA)
01

Overview

The "novel transcript, antisense to LASP1" (ENSG00000265784) is an annotated, uncharacterized RNA gene located antisense to the LASP1 gene region. It is most likely a long non-coding RNA (lncRNA), but it has not been functionally validated, and no data are available regarding its molecular function, biological role, or disease relevance[3]. There is no evidence that it encodes a protein, participates in known regulatory networks, or serves as a biomarker or drug target. Context and distinction: - This target should not be confused with the protein LASP1 (LIM and SH3 domain protein 1), which is a well-studied protein implicated in cancer, cell signaling, cytoskeletal regulation, and other biological processes[1][2][4]. The details in sources [1], [2], and [4] pertain to the LASP1 protein, not to the antisense transcript referenced by ENSG00000265784. - Inclusion as a drug target, receptor, or actionable therapeutic is not appropriate for this specific transcript with current knowledge. Summary: This entry is an uncharacterized, predicted antisense RNA with no known molecular function, disease links, or therapeutic interactions. If a druggable or biologically significant target is intended, LASP1 (protein) rather than its antisense transcript should be referenced[1][2][4].

Other names
ENSG00000265784LASP1-AS

Beyond the preview

Go deeper on Novel transcript, antisense to LASP1.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novel transcript, antisense to LASP1.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call